Envestnet Asset Management
LXRX icon

Envestnet Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Envestnet Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-83,407
Closed -$166K – 3145
2020
Q2 		$166K Buy
+83,407
New +$163K ﹤0.01% 2910
2017
Q4 		– Sell
-2,114
Closed -$26K – 2985
2017
Q3 		$26K Buy
2,114
+110
+5% +$1.62K ﹤0.01% 2447
2017
Q2 		$32K Buy
2,004
+111
+6% +$1.72K ﹤0.01% 2481
2017
Q1 		$27K Buy
1,893
+23
+1% +$341 ﹤0.01% 2604
2016
Q4 		$25K Buy
1,870
+320
+21% +$5.13K ﹤0.01% 2616
2016
Q3 		$28K Sell
1,550
-95
-6% -$1.53K ﹤0.01% 2750
2016
Q2 		$24K Sell
1,645
-345
-17% -$4.68K ﹤0.01% 2938
2016
Q1 		$24K Buy
+1,990
New +$20.9K ﹤0.01% 2932

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.7B AUM 22.47% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return